journal article·2018-07-31

Disruption of Tumor Cells Using a pH-Activated and Thermosensitive Antitumor Lipopeptide Containing a Leucine Zipper Structure

Sijia Wang, Tong Wang, Junqi Zhang, Shouhong Xu, Honglai Liu

Langmuir· Volume 34· Issue 30
Publisher page

Abstract

Antitumor peptides may potentially alleviate the problem of chemoresistance but do not yet target tumor cells and would be cytotoxic to normal cells. Here, we designed a pH-activated and thermosensitive lipopeptide (C6-Pep) containing a leucine zipper and an alkyl chain and assessed the ability of C6-Pep to kill cancer cells. Pep, the same sequence without the N-terminal hexanoic acid moiety, was generated as a less hydrophobic control. First, lipopeptide adsorption into lipid monolayers was studied using Langmuir-Blodgett and polarization modulation infrared reflection adsorption spectroscopy. Under weakly acid conditions, electrostatic interactions between C6-Pep and negatively charged phospholipids increased the adsorption/insertion of C6-Pep (vs Pep) into lipid monolayers. Cargo leakage from liposomes was assayed to model lipopeptide-induced lipid membrane disruption. The ability of C6-Pep to disrupt liposomes depended on the peptide molecular structure/hydrophobicity, solution pH, and temperature-induced uncoiling of the zipper structure; the greatest cargo leakage from the liposome with negative charge was observed for C6-Pep at pH 5.5 under mildly hyperthermic conditions (45 °C). In vitro, C6-Pep was significantly more cytotoxic toward HeLa cells at pH 5.5 under hyperthermic conditions than at pH 7.4 and/or 37 °C. Overall, this study demonstrates that amphipathic C6-Pep can insert into cell membranes in the low-pH tumor microenvironment, whereas the application of heat promotes the uncoiling of the zipper structure, leading to the disruption of tumor cell membranes and cell death. pH-activated and thermosensitive C6-Pep represents a promising tool to kill cancer cells via a strategy that does not invoke chemoresistance and may have low side effects.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Antimicrobial Peptides and Activities · Lipid Membrane Structure and Behavior · RNA Interference and Gene Delivery

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Key Laboratory for Advanced Materials, School of Chemistry and Molecular Engineering, East China University of Science and Technology, Shanghai 200237, PR China

Key Laboratory of Medical Molecular Virology (MOE & MOH), School of Basic Medical Sciences, Fudan University, Shanghai 200032, PR China

Funding

National Natural Science Foundation of China

References (53)

Show source-provided references
1. 10.1021/id500052s10.1021/id500052s ↗
2. 10.1021/acsnano.7b0226710.1021/acsnano.7b02267 ↗
3. 10.1021/acs.jmedchem.7b0021510.1021/acs.jmedchem.7b00215 ↗
4. 10.1021/acsinfecdis.7b0007110.1021/acsinfecdis.7b00071 ↗
5. 10.1021/cr030100y10.1021/cr030100y ↗
6. 10.1021/am100172g10.1021/am100172g ↗
7. 10.1039/C4CC03001J10.1039/C4CC03001J ↗
8. 10.1021/bi000946l10.1021/bi000946l ↗
9. 10.1021/bk-2008-0984.ch00410.1021/bk-2008-0984.ch004 ↗
10. 10.1021/bm500101w10.1021/bm500101w ↗
11. 10.1021/acs.jmedchem.5b0201610.1021/acs.jmedchem.5b02016 ↗
12. 10.1021/ja026087110.1021/ja0260871 ↗
13. 10.3390/antibiotics304061710.3390/antibiotics3040617 ↗
14. 10.1021/acs.biomac.6b0128510.1021/acs.biomac.6b01285 ↗
15. 10.1038/nature0523310.1038/nature05233 ↗
16. 10.1021/am504973d10.1021/am504973d ↗
17. 10.1021/acsami.5b0454710.1021/acsami.5b04547 ↗
18. 10.1021/acs.langmuir.5b0153310.1021/acs.langmuir.5b01533 ↗
19. 10.1021/acschembio.6b0084310.1021/acschembio.6b00843 ↗
20. 10.1172/JCI9395510.1172/JCI93955 ↗
21. 10.1021/bc800132p10.1021/bc800132p ↗
22. 10.1021/acs.langmuir.6b0398610.1021/acs.langmuir.6b03986 ↗
23. 10.1021/ja102167m10.1021/ja102167m ↗
24. 10.1038/nature1113010.1038/nature11130 ↗
25. 10.1016/j.peptides.2010.08.00710.1016/j.peptides.2010.08.007 ↗
26. 10.1021/mp400052s10.1021/mp400052s ↗
27. 10.1021/bi971424h10.1021/bi971424h ↗
28. 10.1039/C6CP00378H10.1039/C6CP00378H ↗
29. 10.1021/acs.langmuir.6b0408010.1021/acs.langmuir.6b04080 ↗
30. 10.1021/acs.langmuir.6b0293710.1021/acs.langmuir.6b02937 ↗
31. 10.1016/j.bbamem.2005.08.00310.1016/j.bbamem.2005.08.003 ↗
32. 10.1021/acsami.6b1230710.1021/acsami.6b12307 ↗
33. 10.1021/la501680310.1021/la5016803 ↗
34. 10.1021/ma052055x10.1021/ma052055x ↗
35. 10.1016/j.colsurfb.2014.12.03310.1016/j.colsurfb.2014.12.033 ↗
36. 10.1016/j.msec.2014.11.06110.1016/j.msec.2014.11.061 ↗
37. 10.1021/acsomega.6b0007910.1021/acsomega.6b00079 ↗
38. 10.1021/bm900500310.1021/bm9005003 ↗
39. 10.1021/ac401254s10.1021/ac401254s ↗
40. 10.1021/ma400484b10.1021/ma400484b ↗
41. 10.1021/acs.jmedchem.6b0092210.1021/acs.jmedchem.6b00922 ↗
42. 10.1093/protein/5.3.19110.1093/protein/5.3.191 ↗
43. 10.1002/1097-0282(200012)54:7<531::AID-BIP60>3.0.CO;2-X10.1002/1097-0282(200012)54:7<531::AID-BIP60>3.0.CO;2-X ↗
44. 10.1021/la062534510.1021/la0625345 ↗
45. 10.1016/j.jcis.2013.04.00510.1016/j.jcis.2013.04.005 ↗
46. 10.1016/j.jcis.2014.05.05010.1016/j.jcis.2014.05.050 ↗
47. 10.1002/bip.2016510.1002/bip.20165 ↗
48. 10.1007/s00396-009-2068-210.1007/s00396-009-2068-2 ↗
49. 10.1016/0927-7757(94)03061-410.1016/0927-7757(94)03061-4 ↗
50. 10.1021/bi201335t10.1021/bi201335t ↗
51. 10.1021/jacs.5b1249110.1021/jacs.5b12491 ↗
52. 10.1021/la504752u10.1021/la504752u ↗
53. 10.1021/bm101165e10.1021/bm101165e ↗